FLF hosts first International Summit in Tel Aviv The Follicular Lymphoma Foundation (FLF) proudly hosted its first international FL Summit, titled “Joining Forces to Cure Follicular Lymphoma,” in Tel Aviv, Israel.The summit, held in January 2023, exceeded...
FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting and Exposition, in New Orleans Louisiana, USA from the 10th to the 13th December 2022.The FLF team will be attending sessions, building...
New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to lead new and determined efforts to find innovative treatments and cures for Follicular Lymphoma (FL). In pursuit of this, the CURE FL Awards...
Kate Rogers our new CEO July 15, 2022 Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director and Audit Committee Chair for Ixico Plc, a Medical Imaging company for...
The FLF announces appointment of its first chief medical officer June 22, 2021 Dr Mitchell Smith brings to the FLF over three decades of experience focused on blood cancers.The Follicular Lymphoma Foundation (FLF) has today announced the appointment of Dr Mitchell...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
